RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells

about

Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.

P2860

Q46246849-EA39BCF9-F4E7-4428-8699-CA086C3BB3AF

P2860

RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells

Item

http://www.wikidata.org/entity/Q38758034

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

RARα2 and PML-RAR similarities ...... f acute myeloid leukemia cells

@en

type

Item

label

RARα2 and PML-RAR similarities ...... f acute myeloid leukemia cells

@en

prefLabel

RARα2 and PML-RAR similarities ...... f acute myeloid leukemia cells

@en

P1476

RARα2 and PML-RAR similarities ...... f acute myeloid leukemia cells

@en

P2093

Adriana Zanetti

http://www.w3.org/2001/XMLSchema#string

Alessandro Rambaldi

http://www.w3.org/2001/XMLSchema#string

Cecile Rochette-Egly

http://www.w3.org/2001/XMLSchema#string

Gianmaria Borleri

http://www.w3.org/2001/XMLSchema#string

Mami Kurosaki

http://www.w3.org/2001/XMLSchema#string

Marco Bolis

http://www.w3.org/2001/XMLSchema#string

Maurizio Gianni

http://www.w3.org/2001/XMLSchema#string

P2860

Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663

P38MAPK-dependent phosphorylation and degradation of SRC-3/AIB1 and RARalpha-mediated transcription

The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies

A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.

Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.

Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia

A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters

The RXR heterodimers and orphan receptors

P304

37041-37060

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.10556

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27419624

http://www.w3.org/2001/XMLSchema#string

P932

5514891

http://www.w3.org/2001/XMLSchema#string

RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells

about

P2860

P2860

RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932